Treatments
NovalGen is focused on multi-specific antibody treatments and is developing groundbreaking therapies for autoimmune disease, cancer and haematology.
We work with families and patient organisations to ensure our programmes deliver the best treatments for patients.
NovalGen is focused on multi-specific antibody treatments and is developing groundbreaking therapies for autoimmune disease, cancer and haematology.
NovalGen is committed to developing innovative treatments. We operate with integrity and carefully test our new treatments in well-designed clinical trials to ensure safety and efficacy.